Resistant cancer
Resistant cancer is a term used to describe cancer types that do not respond to standard treatments. This resistance can be inherent or acquired. Inherent resistance refers to the natural ability of certain cancers to resist treatment, while acquired resistance develops over time due to the adaptation of cancer cells to the treatments used.
Causes[edit | edit source]
The causes of resistant cancer are complex and multifactorial. They can be broadly divided into two categories: tumor cell-intrinsic factors and tumor microenvironment factors.
Tumor cell-intrinsic factors[edit | edit source]
These factors are related to the genetic and epigenetic changes in the cancer cells themselves. They include mutations, gene amplification, and epigenetic changes that lead to the overexpression of drug efflux pumps, alterations in drug targets, and defects in cell death pathways.
Tumor microenvironment factors[edit | edit source]
These factors are related to the physical and biochemical environment in which the tumor cells reside. They include hypoxia, acidic pH, and the presence of stromal cells and immune cells that can protect the tumor cells from the effects of treatment.
Treatment[edit | edit source]
The treatment of resistant cancer is challenging and often requires a multidisciplinary approach. This may include the use of chemotherapeutic agents that are not cross-resistant with the initial treatment, the use of radiation, surgery, and/or immunotherapy. In some cases, clinical trials of new drugs or treatment strategies may be an option.
Research[edit | edit source]
Research into resistant cancer is ongoing and focuses on understanding the mechanisms of resistance and developing new strategies to overcome it. This includes the development of new drugs that can target the specific genetic and epigenetic changes in resistant cancer cells, as well as strategies to modulate the tumor microenvironment to make it less conducive to resistance.
See also[edit | edit source]
| Resistant cancer Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
